Healthcare Utilization in Liver Cirrhosis Patients, a Multicenter Retrospective Cohort Study
Sponsor
Maastricht University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06150482
Collaborator
Maastricht University Medical Center (Other), Gelre Hospitals (Other)
600
2
24
300
12.5
Study Details
Study Description
Brief Summary
Multicenter, retrospective cohort study investigating healthcare utilization in compensated and decompensated liver cirrhosis patients, including disease course and characteristics associated with healthcare utilization and, for example psychosocial factors.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
600 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Healthcare Utilization in Liver Cirrhosis Patients, a Multicenter Retrospective Cohort Study
Actual Study Start Date
:
Sep 1, 2022
Anticipated Primary Completion Date
:
Aug 1, 2024
Anticipated Study Completion Date
:
Sep 1, 2024
Outcome Measures
Primary Outcome Measures
- Number of liver cirrhosis related outpatient contacts before liver cirrhosis complications [2 years before complication, death or loss to follow-up]
- Number of liver cirrhosis related radiographic imaging before liver cirrhosis complications [2 years before complication, death or loss to follow-up]
- Number of liver cirrhosis related esophagogastroscopies before liver cirrhosis complications [2 years before complication, death or loss to follow-up]
- Number of liver cirrhosis related elastographies before liver cirrhosis complications [2 years before complication, death or loss to follow-up]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Patients ≥ 18 years of age
-
Liver cirrhosis, based on biopsy, fibroscan or diagnostic imaging data
Exclusion Criteria:
-
Known malignancy with hepatic metastasis at baseline
-
Liver transplantation at baseline
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Gelre Ziekenhuizen | Apeldoorn | Gelderland | Netherlands | 7334 DZ |
| 2 | Maastricht University Medical Center | Maastricht | Limburg | Netherlands | 6202 AZ |
Sponsors and Collaborators
- Maastricht University
- Maastricht University Medical Center
- Gelre Hospitals
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Maastricht University
ClinicalTrials.gov Identifier:
NCT06150482
Other Study ID Numbers:
- 2021-2857-A-2
First Posted:
Nov 29, 2023
Last Update Posted:
Nov 29, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: